424 related articles for article (PubMed ID: 24650269)
41. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
42. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
[TBL] [Abstract][Full Text] [Related]
43. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
44. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
45. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
Ling Y; Tang S; Cao Y; Fu C
Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
[TBL] [Abstract][Full Text] [Related]
46. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
[TBL] [Abstract][Full Text] [Related]
47. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
48. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
49. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
da Silva IT; Timm Ade S; Damasceno NR
Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
[TBL] [Abstract][Full Text] [Related]
50. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
51. Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.
Huang Y; Wu Y; Yang Y; Li W; Lu J; Hu Y
Sci Rep; 2017 Nov; 7(1):16092. PubMed ID: 29170433
[TBL] [Abstract][Full Text] [Related]
52. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
[TBL] [Abstract][Full Text] [Related]
53. The relationships between biological novel biomarkers Lp-PLA
Chen Y; Wang S; Li J; Fu Y; Chen P; Liu X; Zhang J; Sun L; Zhang R; Li X; Liu L
J Diabetes; 2024 Jul; 16(7):e13574. PubMed ID: 38924255
[TBL] [Abstract][Full Text] [Related]
54. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
[TBL] [Abstract][Full Text] [Related]
55. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
[TBL] [Abstract][Full Text] [Related]
56. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
Tellis CC; Tselepis AD
Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
[TBL] [Abstract][Full Text] [Related]
57. Lp-PLA2 levels in HIV-infected patients.
Díaz-Pollán B; Estrada V; Fuentes-Ferrer M; Gómez-Garré D; San Román-Montero J
J Int AIDS Soc; 2014; 17(4 Suppl 3):19721. PubMed ID: 25397467
[TBL] [Abstract][Full Text] [Related]
58. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
[TBL] [Abstract][Full Text] [Related]
59. Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.
Wooten JS; Nambi P; Gillard BK; Pownall HJ; Coraza I; Scott LW; Nambi V; Ballantyne CM; Balasubramanyam A
Med Sci Sports Exerc; 2013 Jun; 45(6):1043-50. PubMed ID: 23299761
[TBL] [Abstract][Full Text] [Related]
60. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
Li J; Zhou Z; Niu X; Li H
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
